This website will serve as a unique resource for Merkell cell carcinoma patients and their physicians. Written and conceived together with Sheela Gupta and Linda Wang and implemented by Digizyme, Inc. Click here to view website.
Douglas is a senior at MIT majoring in Biology. He will be working on the transgenic mouse project with a focus on primary keratinocytes.
Adam is a junior at Tufts University majoring in Biology. He will be responsible for maintaining our transgenic mice and focusing on carcinogenesis.
Dr. Kawasumi is working on the development small molecule inhibitors of ATR.
In an ongoing collaboration with Dr. Vicente Planelle's laboratory, ATR has been shown to play a key role in the cellular response to HIV-1 infection in two papers. [MCB 200] & [JBL 203]